Rchr
J-GLOBAL ID:202201002658970570   Update date: Aug. 06, 2024

Yoshimoto Ryo

ヨシモト リョウ | Yoshimoto Ryo
Affiliation and department:
Job title: Professor
Research field  (2): Veterinary medicine ,  Pharmacology
Research keywords  (4): 中鎖脂肪酸 ,  肥満 ,  サルコペニア ,  創薬
Research theme for competitive and other funds  (1):
  • 2010 - 2011 Role of LOX-1 in the development of non-alcoholic steat ohepatitis(NASH)
Papers (35):
  • Ayumi Kato, Mana Ito, Takao Sanaki, Tomohiko Okuda, Noriko Tsuchiya, Ryo Yoshimoto, Hideo Yukioka. Acsl1 is essential for skin barrier function through the activation of linoleic acid and biosynthesis of ω-O-acylceramide in mice. Biochimica et biophysica acta. Molecular and cell biology of lipids. 2022. 1867. 2. 159085-159085
  • Kyohei Hayashi, Noriyasu Kondo, Naoki Omori, Ryo Yoshimoto, Megumi Hato, Shuhei Shigaki, Ayumi Nagasawa, Mana Ito, Takayuki Okuno. Discovery of a benzimidazole series as the first highly potent and selective ACSL1 inhibitors. Bioorganic & medicinal chemistry letters. 2021. 33. 127722-127722
  • Kosuke Takemoto, Yumiko Fukasaka, Ryo Yoshimoto, Hirohide Nambu, Hideo Yukioka. Diacylglycerol acyltransferase 1/2 inhibition induces dysregulation of fatty acid metabolism and leads to intestinal barrier failure and diarrhea in mice. Physiological reports. 2020. 8. 15. e14542
  • Masatoshi Hori, Futoshi Yazama, Yasuhiro Matsuura, Ryo Yoshimoto, Takeharu Kaneda, Takeshi Yasumoto, Hiroshi Ozaki, Hideaki Karaki. Inhibition of actin polymerization by marine toxin pectenotoxin-2. The Journal of veterinary medical science. 2018. 80. 2. 225-234
  • Jinqi Liu, Judith N Gorski, Stephen J Gold, Dunlu Chen, Shirley Chen, Gail Forrest, Yoshiki Itoh, Donald J Marsh, David G McLaren, Zhu Shen, et al. Pharmacological inhibition of diacylglycerol acyltransferase 1 reduces body weight and modulates gut peptide release--potential insight into mechanism of action. Obesity (Silver Spring, Md.). 2013. 21. 7. 1406-15
more...
MISC (6):
  • 善本 亮, 西塚 太一, 中野 厚史, 藤田 佳子, 垣野 明美, 高谷 智英, 沢村 達也. プロシアニジンは酸化LDLとLOX-1の結合を阻害し、血管壁脂質沈着を抑制する. 生存科学B. 2012. 22. 27-43
  • 垣野 明美, 西塚 太一, 藤田 佳子, 佐藤 優子, 中野 厚史, 善本 亮, 沢村 達也. 天然物から見出したLOX-1アンタゴニスト・プロシアニジンはSHRSP血管壁への脂質沈着を抑制する. 日本内分泌学会雑誌. 2011. 87. 2. 789-789
  • Taichi Nishizuka, Yoshiko Fujita, Yuko Sato, Atushi Nakano, Akemi Kakino, Shunji Ohshima, Tomomasa Kanda, Ryo Yoshimoto, Tatsuya Sawamura. Procyanidins are potent inhibitors of LOX-1: a new player in the French Paradox (vol 87, pg 104, 2011). PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES. 2011. 87. 7. 431-431
  • Yoshiko Fujita, Akemi Kakino, Yuko Sato, Ryo Yoshimoto, Tatsuya Sawamura. C-reactive protein (CRP) uptake by macrophage via class A scavenger receptor (SR-A). JOURNAL OF PHARMACOLOGICAL SCIENCES. 2010. 112. 61P-61P
  • 堀 正敏, 松浦 康浩, 善本 亮, 尾崎 博, 安元 健, 唐木 英明. 海洋由来天然生理活性物質,ペクテノトキシン-2のアクチン重合阻害作用. 日本薬理学雑誌. 1999. 114. 補冊1. 225P-229P
more...
Books (2):
  • 獣医薬理学 <第2版>
    近代出版 2021
  • ヒスタミンH3受容体アゴニストを用いたメタボリックシンドロームの治療・予防の可能性
    Bionics(オーム社) 2007
Lectures and oral presentations  (35):
  • 運動による過負荷時・廃用からの再負荷時における筋形成過程の寄与
    (日本筋学会学術集会プログラム・抄録集 2018)
  • 3次元培養システムを活用したin vitro筋機能評価への取り組み
    (日本筋学会学術集会プログラム・抄録集 2018)
  • Effects of 11b-HSD1 inhibitor on the muscle atrophy induced by the glucocorticoid excess.
    (8th International Conference on Cachexia, Sarcopenia and Muscle Wasting, Paris, France 1900)
  • 雄ラットにおけるStreptozotocin 誘発性膵島腫瘍の病理学的及び網羅的遺伝子解析
    (第31回日本毒性病理学会総会)
  • Procyanidin is a naturally-occurnig LOX-1 antagonist and inhibits lipid accumulation in vascular wall.
    (第84回日本薬理学会年会、横浜)
more...
Education (1):
  • 1997 - 2001 The University of Tokyo
Work history (4):
  • 2022/04 - 現在 Azabu University
  • 2011/07 - 2022/03 塩野義製薬株式会社 医薬研究本部
  • 2009/06 - 2011/06 National Cerebral and Cardiovascular Center, Research Institute
  • 2001/04 - 2009/05 万有製薬株式会社 つくば研究所
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page